Comparison of 0.5mg/kg and 1.0mg/kg Suxamethonium in patients undergoing Electroconvulsive Therapy (ECT)
Comparison of 0.5mg/kg and 1mg/kg Suxamethonium in patients undergoing voluntary ECT(Electroconvulsive Therapy)
Peninsula Health
50 participants
Feb 1, 2009
Interventional
Conditions
Summary
Patients undergoing ECT often experience postprocedure myalgia. There is also a published range of muscle relaxant doses to minimise this occurrence. It is the purpose of this study to compare the higher and lower recommended doses to see if there is a difference in postprocedure myalgia between the two doses.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
comparison two doses of suxamethonium in ECT. suxamethonium is a muscle relaxant administered intravenously at the time of ECT to reduce muscle spasms. It will be administered in this way on two consecutive occasions within a week of each other at the time of ECT. On one occassion, the dosage amount of Suxamethonium administered to participants will be 1.0mg/kg
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000072213